On the biomedical promise of cell penetrating peptides: Limits versus prospects

被引:122
作者
Foerg, Christina [1 ]
Merkle, Hans P. [1 ]
机构
[1] ETH, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland
关键词
cell penetrating peptides; drug delivery; cellular translocation; endocytosis; tight junctions; cellular differentiation; Rho-GTPases; inflammatory model; review;
D O I
10.1002/jps.21117
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The cell membrane poses a substantial hurdle to the use of pharmacologically active biomacromolecules that are not per se actively translocated into cells. An appealing approach to deliver such molecules involves tethering or complexing them with so-called cell penetrating peptides (CPPs) that are able to cross the plasma membrane of mammalian cells. The CPP approach is currently a major avenue in engineering delivery systems that are hoped to mediate the non-invasive import of problematic cargos into cells. The large number of different cargo molecules that have been efficiently delivered by CPPs ranges from small molecules to proteins and even liposomes and particles. With respect to the involved mechanism(s) there is increasing evidence for endocytosis as a major route of entry. Moreover, in terms of intracellular trafficking, current data argues for the transport to acidic early endosomal compartments with cytosolic release mediated via retrograde delivery through the Golgi apparatus and the endoplasmic reticulum. The focus of this review is to revisit the performance of cell penetrating peptides for drug delivery. To this aim we cover both accomplishments and failures and report on new prospects of the CPP approach. Besides a selection of successful case histories of CPPs we also review the limitations of CPP mediated translocation. In particular, we comment on the impact of (i) metabolic degradation, (ii) the cell line and cellular differentiation state dependent uptake of CPPs, as well as (iii) the regulation of their endocytic traffic by Rho-family GTPases. Further on, we aim at the identification of promising niches for CPP application in drug delivery. In this context, as inspired by current literature, we focus on three principal areas: (i) the delivery of antineoplastic agents, (ii) the delivery of CPPs as antimicrobials, and (iii) the potential of CPPs to target inflammatory tissues. (C) 2007 Wiley-Liss, Inc. and the American Pharmacists Association.
引用
收藏
页码:144 / 162
页数:19
相关论文
共 169 条
[1]   Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors [J].
Al-Taei, S ;
Penning, NA ;
Simpson, JC ;
Futaki, S ;
Takeuchi, T ;
Nakase, I ;
Jones, AT .
BIOCONJUGATE CHEMISTRY, 2006, 17 (01) :90-100
[2]   Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates [J].
Astriab-Fisher, A ;
Sergueev, DS ;
Fisher, M ;
Shaw, BR ;
Juliano, RL .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (01) :83-90
[3]   Transduction of TAT-HA-β-galactosidase fusion protein into salivary gland-derived cells and organ cultures of the developing gland, and into rat submandibular gland in vivo [J].
Barka, T ;
Gresik, EW ;
van der Noen, H .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2000, 48 (11) :1453-1460
[4]   A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia [J].
Borsello, T ;
Clarke, PGH ;
Hirt, L ;
Vercelli, A ;
Repici, M ;
Schorderet, DF ;
Bogousslavsky, J ;
Bonny, C .
NATURE MEDICINE, 2003, 9 (09) :1180-1186
[5]   GTPASES - A TURN-ON AND A SURPRISE [J].
BOURNE, HR .
NATURE, 1993, 366 (6456) :628-629
[6]   A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA [J].
Brandén, LJ ;
Mohamed, AJ ;
Smith, CIE .
NATURE BIOTECHNOLOGY, 1999, 17 (08) :784-787
[7]   Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms [J].
Bruewer, M ;
Luegering, A ;
Kucharzik, T ;
Parkos, CA ;
Madara, JL ;
Hopkins, AM ;
Nusrat, A .
JOURNAL OF IMMUNOLOGY, 2003, 171 (11) :6164-6172
[8]   In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation [J].
Bucci, M ;
Gratton, JP ;
Rudic, RD ;
Acevedo, L ;
Roviezzo, F ;
Cirino, G ;
Sessa, WC .
NATURE MEDICINE, 2000, 6 (12) :1362-1367
[9]  
Cao GD, 2002, J NEUROSCI, V22, P5423
[10]   Intracellular delivery of a Tat-eGFP fusion protein into muscle cells [J].
Caron, NJ ;
Torrente, Y ;
Camirand, G ;
Bujold, M ;
Chapdelaine, P ;
Leriche, K ;
Bresolin, N ;
Tremblay, JP .
MOLECULAR THERAPY, 2001, 3 (03) :310-318